Jianming Guo

Fixed-dose administration and pharmacokinetically guided adjustment of busulfan dose for patients undergoing hematopoietic stem cell transplantation: a meta-analysis and cost-effectiveness analysis

Maobai Liu, B. Zheng, Chaoxin Chen, 2022, Annals of Hematology.

Systematic review and cost-effectiveness of pharmacokinetically guided sunitinib individualized treatment for patients with metastatic renal cell carcinoma

Maobai Liu, B. Zheng, Chaoxin Chen, 2022, Therapeutic advances in medical oncology.

Predicting the Stone-Free Status of Percutaneous Nephrolithotomy With the Machine Learning System: Comparative Analysis With Guy’s Stone Score and the S.T.O.N.E Score System

Hang Wang, Jianming Guo, Hong Zhao, 2022, Frontiers in Pharmacology.

Alternative Complement Pathway Signature Determines Immunosuppression and Resistance to Immunotherapy Plus Tyrosine Kinase Inhibitor Combinations in Renal Cell Carcinoma.

Yan-jun Zhu, Ying Wang, Xianglai Xu, 2022, Urologic oncology.

Predictive Factors for Acute Kidney Injury and Long-term Renal Function Loss After Partial Nephrectomy: A Prospective Single-Center Study.

Hang Wang, P. Xu, Sihong Zhang, 2022, Urology.

Prognostic evaluation based on radiological morphological characteristic for tumors larger than 7 cm in renal cell carcinoma

Hang Wang, Jianjun Zhou, P. Xu, 2022, Journal of Cancer Research and Clinical Oncology.

Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle‐invasive bladder cancer: A multi‐center, single‐arm, phase 2 study

W. Wang, Wanhai Xu, Shouzhen Chen, 2023, Cancer medicine.

Development and validation of a nomogram to evaluate the therapeutic effects of second-line axitinib in patients with metastatic renal cell carcinoma

Hang Wang, Dengqiang Lin, Xiaoyi Hu, 2023, Frontiers in Oncology.